The global bio pharma logistics market revenue was around US$ 96.46 billion in 2022 and is estimated to reach US$ 180.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2023 to 2031.
Biopharma logistics is the logistics of pharmaceuticals, vaccines, medical and surgical supplies, medical equipment and devices, and other products required to support nurses, doctors, and other health and dental care providers. Biopharmaceutical logistics is unique in that it desires to optimize effectiveness rather than efficiency because its final consumers are responsible for the health and lives of their patients.
Market Driving Factors
The development of novel biological therapies and drugs drives the market growth. The emergence of biologics such as recombinant proteins, monoclonal antibodies, and gene and cell therapies led to robust pipeline growth and new product approvals. This raised the requirement for temperature-controlled logistics to maintain product goodness during storage and transportation.
Bio-pharma companies are surging the outsourcing of supply chain activities to third-party logistics providers to optimize price, improve reliability, and gain access to specialized expertise. Logistics partners provide end-to-end services ranging from strategic planning to implementation. In addition, their expertise in compliant temperature-controlled distribution and trade lane ability decreases hazards involved in bio-pharma product movement. Thus, the increasing demand for outsourced logistics services boosts the market growth.
The high price of logistics limits the market growth.
Regional Analysis
North America dominated the market in terms of the largest share and is estimated to maintain its dominance over the forecast period. This can be attributed to the increase in biopharmaceutical development and research, along with a constant rise in FDA-approved products, which has stimulated demand for specialized logistics services. Furthermore, strict regulatory needs have further emphasized the requirement for compliant storage and transportation solutions. In addition, technical advances in real-time tracking systems and cold chain management have strengthened the region's ability to handle temperature-sensitive pharmaceuticals.
Asia-Pacific dominates the market in terms of revenue. This is due to the expanding healthcare sector, coupled with an increase in pharmaceutical production, which has surged the demand for specialized logistics services. Furthermore, the increase in biopharmaceutical development and research, including vaccines and cutting-edge therapies, has necessitated strict temperature-controlled transportation. In addition, regulatory compliance and quality assurance standards drive the requirement for cutting-edge logistics solutions.
Segmentation Insights
Type Insight
The cold chain logistics segment is estimated to dominate the market. This is due to the rising demand for temperature-sensitive biopharmaceuticals such as gene therapies and vaccines, which need specialized handling and transportation protocols. As a result, there is an increasing demand for cutting-edge cold chain solutions.
Service Type Insight
The warehousing segment dominates the market in terms of the share. The increasing biopharmaceutical industry has prompted the requirement for compliant and dedicated storage facilities. These facilities must fulfill stringent regulatory needs for security, temperature control, and quality assurance. In addition, the surge in the complexity of pharmaceutical supply chains has necessitated the growth of warehousing capacity to assure efficient and punctual deliveries.
Mode of Transportation Insight
The airways segment dominates the market. This is because of the time-sensitive nature of pharmaceuticals, particularly vaccines and biopharmaceuticals, immediate demands, and reliable transportation. In addition, airways offer the fastest mode of transit, which is essential for fulfilling global healthcare requirements. Technological advances, including real-time tracking systems and temperature-controlled cargo holds, have boosted the segment's capabilities.
Prominent Companies
Segmentation Outline
The global bio pharma logistics market segmentation focuses on Type, Service Type, Mode of Transportation, and Region.
By Type
By Service Type
By Mode of Transportation
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL BIO PHARMA LOGISTICS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: BIO PHARMA LOGISTICS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL BIO PHARMA LOGISTICS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL BIO PHARMA LOGISTICS MARKET, BY TYPE
5.1 OVERVIEW
5.2 COLD CHAIN LOGISTICS
5.3 NON-COLD CHAIN LOGISTICS
6 GLOBAL BIO PHARMA LOGISTICS MARKET, BY SERVICE TYPE
6.1 OVERVIEW
6.2 WAREHOUSING
6.3 TRANSPORTATION
6.4 PACKAGING
6.5 OTHERS
7 GLOBAL BIO PHARMA LOGISTICS MARKET, BY MODE OF TRANSPORTATION
7.1 OVERVIEW
7.2 ROADWAYS
7.3 SEA
7.4 AIRWAYS
7.5 RAILWAYS
8 GLOBAL BIO PHARMA LOGISTICS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL BIO PHARMA LOGISTICS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 AMERISOURCEBERGEN CORPORATION
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 CEVA LOGISTICS AG
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 DHL INTERNATIONAL GMBH
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 FEDEX CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 FISHER CLINICAL SERVICES, INC
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 KUEHNE + NAGEL INTERNATIONAL AG
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 MARKEN
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 PANALPINA WORLD TRANSPORT (HOLDING) LTD
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 QUICKSTAT
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 SF EXPRESS CO. LTD
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 SKYCELL AG
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 UPS (UNITED PARCEL SERVICE, INC.)
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 VERSACOLD LOGISTICS SERVICES
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 WORLD COURIER, A PART OF AMERISOURCEBERGEN
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 ZUELLIG PHARMA HOLDINGS PTE. LTD
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved